Latest News in Pharma industry
Big Pharma's China Problem: GSK's Upcoming Layoffs Show How Multinationals Are Reinventing Themselves
Eli Lilly Builds Powerful NVIDIA Supercomputer to Speed Up Drug Discovery and Transform Pharma with AI
Inside Eli Lilly’s $300 Million Bet: How Obesity Billions Are Fueling a One-Shot Cure for Blindness
Danish Drama: Novo Nordisk's Controlling Foundation Just Staged a Boardroom Takeover
Britain's Big Pharma Bet: Higher Drug Prices for Tariff-Free Access to America
Rani Therapeutics’ Big Comeback: How a Tiny Pill Sent a Penny Stock Soaring 259%
Zongertinib’s 77% Strike: A Precision Weapon Emerges Against Lung Cancer’s Hidden Aggressors
Novo Nordisk’s $5.2B swing at liver disease says the future needs more than weight-loss drugs
Novo Nordisk Bets Big on U.S. Manufacturing: Promise or Pipe Dream?
FDA grants breakthrough status to oral pill that slowed vision loss by half in patients with inherited blinding disease
Amgen's Repatha Becomes First Cholesterol Drug to Prevent Heart Attacks in Patients Who Never Had One, But Access and Cost Questions Shadow Trial Success
Trump Administration Partners with Pfizer to Launch Federal Website Selling Discounted Drugs Directly to Consumers Without Insurance
Emma Walmsley to Step Down as GSK Chief Executive After Nine Years as Company Names Commercial Leader Luke Miels Her Successor
Europe Approves Lilly's Kisunla as First Alzheimer's Drug Designed to Stop When Brain Plaques Clear
Trump Announces 100% Tariffs on Imported Branded Drugs Unless Companies Build US Factories
South Korea’s Celltrion Puts $330M on the Line in U.S. Manufacturing Push
Roche Acquires Liver Disease Biotech 89bio for Up to $3.5 Billion as Pharma Giants Race Beyond Weight Loss Drugs
Lilly Diabetes Drug Beats Novo Nordisk Pill by 73% in Weight Loss During Head-to-Head Trial
Worldwide Clinical Trials Appoints Former Syneos Health CEO Macdonald to Replace Retiring Founder After 11 Years
Revolution Medicines Reports Extended Survival Results for Pancreatic Cancer Drug Ahead of Global Phase 3 Trial Launch
NFL Biosciences Two-Shot Smoking Treatment Shows Partial Success in Phase II Trial Despite Missing Main Target
FDA Approves First At-Home Alzheimer's Injection for Weekly Self-Treatment
Teva Wins FDA Approval for First Generic Weight Loss Drug as Obesity Treatment Market Opens to Competition
Eli Lilly's Daily Weight Loss Pill Succeeds in Major Trial, Clearing Path for First Needle-Free Alternative to Popular Injections
AbbVie Acquires 90-Minute Psychedelic Depression Treatment for $1.2 Billion
Eli Lilly Issues Rare 40-Year Bonds as Long-Term Corporate Debt Nearly Disappears from Markets
FDA Approves First Drug Treatment for Rare Throat Disease That Previously Required Repeated Surgery
FDA Approves First Treatment for Lung Disease That Left 500,000 Americans Without Options
Genmab's New Therapy Slashes Lymphoma Progression Risk by 79% in Global Trial
Novo Nordisk Senior Director's Internal Email Exposes Management Problems Behind Stock Crash
Mounjaro Diabetes Drug Shows 16% Lower Death Rate in Phase 3 Heart Study Against Trulicity
Novo Nordisk Loses $42 Billion in Market Value After 21% Stock Drop on Profit Warning
Eli Lilly Acquires Verve Therapeutics for $1.3 Billion to Develop One-Time Heart Disease Treatments
ImageneBio Launches on Nasdaq Following Merger, Raises $75M for Skin Treatment Development
Abivax Raises $650M at Premium Price After Strong Ulcerative Colitis Drug Results
SEC Probe Sends Telix Stock Down 15% Even as Company Reports 63% Revenue Growth
MEI Pharma Raises $100M to Buy Litecoin, First Public Company to Hold LTC as Treasury Asset
Third Death Sends Sarepta's Gene Therapy Empire Crumbling
National Cancer Institute Launches Major Study of Guardant's Multi-Cancer Blood Test
Ascendis Pharma's New Hypoparathyroidism Drug Frees 96% of Patients From Traditional Treatment in Landmark 3-Year Study
Merck Launches Final Trials for Monthly HIV Prevention Pill with Gates Foundation Support
In Bold Respiratory Play, Merck Bets $10 Billion on Verona's Revolutionary COPD Treatment
Centivax Raises $45M Series A to Advance Universal Flu Vaccine to Human Trials
Proxy Giants Hand Sinovac's Board Lifeline as $10 Billion Battle Reaches Breaking Point
Pharmaceutical Reshoring Continues - Hikma's $1 Billion Bet on American Medicine
A Breakthrough in the Storm - FDA Approves First Treatment for Deadly Inflammatory Condition
Breaking Ground in Addiction Medicine - Achieve Life Sciences' FDA Application Signals First New Smoking Cessation Drug in Two Decades
Pancreatic Cancer Drug Market Set for Threefold Surge as Innovation Pipeline Swells
Actuate Therapeutics Drug Extends Pancreatic Cancer Survival by 4 Months in Phase 2 Trial
Novo Nordisk Terminates Hims & Hers Deal Amid Weight-Loss Drug Compounding Controversy
Load More